Clinical Benefits With Neratinib in HER2+ Early Breast Cancer

Vijayakrishna Gadi, MD, PhD, and Megan Kruse, MD, discuss the clinical benefits reported with neratinib for the treatment of patients with HER2-positive early breast cancer.

Related Keywords

Vijayakrishna Gadi ,Megan Kruse , ,Evolving Adjuvant Treatments ,Early Breast Cancer ,Benefits With Neratinib ,Early Breast ,